N-formylnorleucyl-leucyl-4-phenylalanine: used to demonstrate the specific binding of chemotactic peptides to receptors in rabbit neutrophils
ID Source | ID |
---|---|
PubMed CID | 119508 |
SCHEMBL ID | 1477244 |
MeSH ID | M0083862 |
Synonym |
---|
fnllp |
n-formyl-nle-leu-phe |
61864-82-2 |
l-phenylalanine, n-formyl-l-norleucyl-l-leucyl- |
(2s)-2-[[(2s)-2-[[(2s)-2-formamidohexanoyl]amino]-4-methylpentanoyl]amino]-3-phenylpropanoic acid |
SCHEMBL1477244 |
n-fnlp |
l-phenylalanine, n-(n-(n-formyl-l-norleucyl)-l-leucyl)- |
n-formyl-norleucyl-leucyl-p-phenylalanine |
n-formylnorleucyl-leucyl-4-phenylalanine |
n-formylnorleucyl-leucyl-p-phenylalanine |
n-formyl-nle-leu-p-phe |
formyl-norleucyl-leucyl-phenylalanine |
(s)-2-((s)-2-((s)-2-formamidohexanamido)-4-methylpentanamido)-3-phenylpropanoic acid |
n-[1-hydroxy-2-({1-hydroxy-2-[(hydroxymethylidene)amino]hexylidene}amino)-4-methylpentylidene]phenylalanine |
DTXSID20977427 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 31 (68.89) | 18.7374 |
1990's | 12 (26.67) | 18.2507 |
2000's | 2 (4.44) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (2.22%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 44 (97.78%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |